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Stroke affects 152 000 individuals in the United Kingdom 
per year1 and is the leading cause of adult disability.2 
Approximately a third of individuals with stroke will have 
another stroke,3 and 75% present with cardiac disease.4 
There is a need to develop practical interventions that 
reduce disability levels and prevent stroke recurrence and 
cardiovascular disease.
Stroke recurrence is influenced by a number of modifi-
able metabolic risk factors, including impaired glucose 
control, dyslipidemia, hypertension, obesity, and low car-
diorespiratory fitness.5 Metabolic abnormalities promote 
cellular changes that result in the alteration of the structure 
and function of blood vessels, and this damage can, in turn, 
lead to stroke and other vascular dysfunctions such as 
reduced cerebral blood flow (CBF).6-8 In the healthy popu-
lation, increasing physical activity has been shown to be an 
inexpensive, safe, and effective method of improving meta-
bolic risk factors and vascular control, with minimal side 
effects.9,10 Prospective observational studies in healthy indi-
viduals also indicate that a physically active lifestyle may 
be neuroprotective, preventing age-related decline in CBF, 
brain atrophy, and cognitive function.11,12 Whether exercise 
can be used for similar benefit following stroke, where low 
levels of physical activity are a particular problem,13 has yet 
to be fully defined.14
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Abstract
Background. Exercise therapy could potentially modify metabolic risk factors and brain physiology alongside improving 
function post stroke. Objective. To explore the short-term metabolic, brain, cognitive, and functional effects of exercise 
following stroke. Methods. A total of 40 participants (>50 years, >6 months post stroke, independently mobile) were 
recruited to a single-blind, parallel, randomized controlled trial of community-based exercise (19 weeks, 3 times/wk, 
“exercise” group) or stretching (“control” group). Primary outcome measures were glucose control and cerebral blood 
flow. Secondary outcome measures were cardiorespiratory fitness, blood pressure, lipid profile, body composition, cerebral 
tissue atrophy and regional brain metabolism, and physical and cognitive function. Results. Exercise did not change glucose 
control (homeostasis model assessment 1·5 ± 0·8 to 1·5 ± 0·7 vs 1·6 ± 0·8 to 1·7 ± 0·7, P = .97; CI = −0·5 to 0·49). Medial 
temporal lobe tissue blood flow increased with exercise (38 ± 8 to 42 ± 10 mL/100 g/min; P < .05; CI = 9.0 to 0.1) without 
any change in gray matter tissue volume. There was no change in medial temporal lobe tissue blood flow in the control 
group (41 ± 8 to 40 ± 7 mL/100 g/min; P = .13; CI = −3.6 to 6.7) but significant gray matter atrophy. Cardiorespiratory 
fitness, diastolic blood pressure, high-density lipoprotein cholesterol, physical function, and cognition also improved with 
exercise. Conclusion. Exercise therapy improves short-term metabolic, brain, physical, and cognitive function, without 
changes in glucose control following stroke. The long-term impact of exercise on stroke recurrence, cardiovascular health, 
and disability should now be explored.
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Strong evidence demonstrates that structured exercise 
leads to short- and long-term functional benefits post 
stroke.14 What has not been determined is whether exercise 
therapy can be used to improve function but also to modify 
metabolic and cerebrovascular control in the short-term 
leading to long-term reduction in stroke recurrence and 
improved cardiovascular health. The limited translation of 
current exercise and stroke research findings into clinical 
care15 also highlights a need for the development of feasible 
exercise interventions that can be incorporated into the 
stroke pathway.
This pilot randomized controlled trial aims to explore 
the effects of structured community exercise on metabolic 
risk factors and brain, physical, and cognitive function post 
stroke. The primary hypothesis was that structured exercise 
would improve glucose control and brain blood flow. 
Secondary hypotheses were that structured exercise would 
improve cerebral atrophy/metabolism, cardiorespiratory 
fitness, blood pressure, lipid profile, body composition, 
and clinical outcomes (walking ability, balance, cognition, 
and quality of life) and that exercise would be more effec-
tive than a home stretching program in improving meta-




This was a single-center, single-blind, parallel, randomized 
controlled trial of community exercise therapy compared 
with a control group that did stretching. The study was 
approved by the County Durham and Tees Valley Research 
and Ethics Committee. All participants gave informed writ-
ten consent for the study according to the Declaration of 
Helsinki. The study was conducted from May 2011 to 
February 2012.
Participants
Eligible participants were >50 years old, had had a stroke 
(>6 months previously), were able to complete the 6-minute 
walk test (with/without stick), were living at home, had 
completed all NHS physiotherapy, and were not already 
undertaking regular exercise (≥3 times/wk, moderate inten-
sity). Exclusion criteria were the following: absolute and 
relative contraindications to exercise testing (American 
Heart Association guidelines),16 insulin-dependent diabe-
tes, neurological disorders other than stroke, pain on walk-
ing (>5 on the Visual Analogue Scale), inability to follow 
2-stage commands, cognitive problems (Mini Mental State 
Examination score <24), untreated major depression, and 
contraindications to magnetic resonance (MR) imaging.
Setting
Participants were recruited from stroke services in the North 
East via referral from stroke health professionals or adver-
tisement in the local newspaper.
Structured Exercise Intervention
The intervention was adapted from the Fitness and 
Mobility Exercise program17 (see the appendix) a mixed 
exercise intervention incorporating functional movement 
and previously demonstrated to be effective and feasible 
following stroke.18,19 Briefly, community leisure-center 
classes were run by a physiotherapist and physical activ-
ity instructor for 19 weeks (3 times/wk, 45-60 minutes). 
This duration was selected because interventions of a 
similar length have improved both function20 and glucose 
control post stroke.21 To progress the cardiovascular ele-
ment of the exercise program, a heart rate training zone 
was calculated for participants using the Karvonen for-
mula: [(Heart rate reserve × Training %) + Resting heart 
rate].22 Initially, participants trained at 40% to 50% of 
their maximum heart rate, measured by a heart rate moni-
tor (Polar, Finland), with increasing increments of 10% 
every 4 weeks up to 70% to 80%, as tolerated. Strength/
balance exercises were progressed by increasing repeti-
tions and loading.
Control Intervention
The control group completed a matched-duration home 
stretching program. Stretching was chosen because other 
potential control interventions such as yoga or Tai chi can 
improve metabolic risk factors,23 whereas these benefits 
have not been demonstrated with stretching. Participants 
were given an instruction booklet and diary to record 
stretches and changes in medication/diet/physical activity 
and contacted fortnightly to check progress.
Outcomes
Outcomes were assessed at baseline and within 1 week pos-
tintervention by assessors blinded to the study hypotheses 
and group assignment.
Glucose Control
After a 12-hour fast, glucose and insulin were measured 
before and after a 75-g glucose load, as described previ-
ously.24 The Homeostasis Model Assessment of Insulin 
Sensitivity (HOMA) was used to calculate insulin sensitiv-
ity at baseline: [(Fasting insulin in U/mL × Fasting glucose 
in mmol/L)/22.5].25
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Gray Matter Atrophy, CBF, and Regional 
Metabolism
MR imaging was undertaken preintervention and postinter-
vention to measure cerebral tissue atrophy, blood flow, and 
regional metabolism. This protocol was selected because 
exercise can increase global CBF26 and volume27 and spe-
cifically increase blood flow in the dentate gyrus.28 Imaging 
was performed using a whole-body 3.0T MR scanner 
(Achieva, Philips Medical Systems, Best, Netherlands).
Anatomical T
1
-weighted images were collected (FOV = 
240 × 180 × 216 mm3; TR = 8.3 ms; TE = 4.6 ms) and were 
segmented in SPM8 to produce gray and white matter 
masks from which longitudinal changes in brain structure 
over time were examined using voxel-based morphometry.
CBF was measured using arterial spin labeling (FAIR 
method: TE = 23 ms; TR = 4 s; 4 × 4 × 6 mm3 resolution; 
FOV = 256 × 256 × 84 mm3), with inflow times from 900 to 
2400 ms (300-ms steps). The imaging volume was posi-
tioned parallel to the anterior commissure–posterior com-
missure line, with lower slices covering the hippocampus. 
Perfusion-weighted and magnitude images were computed 
for each inflow time, from which T
1
 and proton density 
maps were derived. The inflow transit delay was computed 
by fitting the perfusion signal versus inflow time to a gen-
eral kinetic model. CBF was then quantified based on per-
fusion signal, proton density images, and transit delay, 
assuming T
1
 of the blood to be 1550 ms and blood-brain 
partition coefficient to be 0.9. Global CBF was measured 
using the gray and white matter masks. Medial temporal 
lobe gray matter blood flow was assessed because it was 
defined as a region of interest from the volumetric scans.
Metabolite data (N-acetylaspartate to total creatine ratio) 
were collected from a single voxel of 40 × 15 × 10 mm3 
covering the dentate gyrus using MR spectroscopy (PRESS; 
TE of 38 ms, TR of 3 s, 128 averages). Spectra were ana-
lyzed in jMRUI software, using the QUEST algorithm.29
Cardiorespiratory Fitness
A maximal progressive recumbent bicycle exercise test was 
undertaken following a previously devised protocol.30 
Briefly, expired gases were analyzed at rest (5 minutes) and 
continuously during the test using a mixing chamber meth-
odology (Metalyzer 3B Cortex, Leipzig, Germany). A 
3-minute warm-up (20 W) was followed by 10-W incre-
ments every minute until the patient was unable to pedal at 
50 revolutions per minute or voluntarily terminated the test.
Resting Blood Pressure
Resting diastolic and systolic blood pressure was recorded 
twice using a semiautomated sphygmomanometer after 10 
minutes sitting.
Lipid Profile
Fasted total cholesterol, triacylglyceride, low-density lipo-
protein cholesterol (LDL-C), and high-density lipoprotein 
cholesterol (HDL-C) were determined preintervention and 
postintervention. Calculation of LDL was done using the 
Friedewald formula.31
Body Composition
Height and weight were measured using a standard rigid 
stadiometer, to the nearest 0.1 cm, and calibrated scales, to 
the nearest 0.2 kg (Seca medical 769 column scale, Chino, 
CA). Body mass index was calculated in kg/m². Body com-
position was measured using air displacement plethysmog-
raphy (BodPod, Life Measurement Inc, CA).32
Physical and Cognitive Outcomes
Preintervention and postintervention assessments consisted 
of the following: (1) physical performance: 6-minute walk 
test,33 10-m walk test,34 and Berg Balance Scale35; (2) cog-
nitive function: Addenbrooke’s Cognitive Examination 
Revised (ACE-R)36; and (3) quality of life: Stroke Impact 
Scale Version 2.0.37
Feasibility Assessment
Protocol feasibility criteria were compliance with the study 
protocol (≥90%); attrition rate (≤10%); clinical safety 
(100%) and effective data processing (100%). Ratings used 
to define study feasibility were: (1) protocol feasible (all 
success criteria achieved); (2) protocol feasible with minor 
modifications (≥75% success criteria achieved); (3) proto-
col feasible with major modifications (≥50% success crite-
ria achieved), and (4) protocol not feasible (none of success 
criteria achieved).38
Safety Outcomes
Exercise testing followed ACSM safety guidelines.39 Trial 
safety reporting was undertaken in line with national 
guidelines.40
Sample Size
For CBF, sample size calculation was based on our previous 
CBF measurements, which showed intraparticipant repro-
ducibility of 8.5%. Effect size was postulated at 10%, which 
is a conservative estimate when compared with animal data 
showing the effect of exercise in a mouse model.28 These 
data indicate that the method has >95% power to detect a 
10% change in CBF, at a significance of P = .01, using pair-
wise measurements in a group of 16 participants.41,42 Sample 
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size was increased to 20 participants to allow for 20% drop-
out. The sample size for metabolic control was determined 
from the published data on the effect of aerobic exercise on 
metabolic control following stroke.21 Based on changes in 
basal insulin (delta 23 ± 35 vs −9 ± 42) and 5% confidence 
level, a sample size of 20 gives >80% power. To provide suf-
ficient power to explore both primary outcomes, we recruited 
20 patients into the intervention and 20 into the control 
group.
Randomization
A computerized random number generator was used to allo-
cate treatment by an independent administrator after screen-
ing. After establishing participant eligibility and consent, 
the administrator was telephoned for the next number in the 
sequence to enable participant randomization.
Statistical Methods
Data were inspected for outliers and assessed for normality 
of distribution. Groups were compared at baseline using an 
independent-sample t test if data conformed to the assump-
tions of normality; if not, the independent-samples Mann 
Whitney U test was applied. Between- and within-group 
differences were assessed from change scores compared 
using independent-sample t tests. Preintervention and pos-
tintervention within-group analyses were performed using a 
paired t test if data conformed to the assumptions of nor-
mality; if not, the Wilcoxon signed-rank test was applied. 
Statistical significance was indicated if P < .05. Data are 
presented as means ± SD unless otherwise indicated.
Results
Participant Flow
Participants were recruited from 2 local stroke services over 
a 6-month period. In all, 400 possible participants were 
screened (see Figure 1 for participant flow) to recruit 40 
participants.
Participant Characteristics
Of the 40 participants, 34 were male and 37 had an ischemic 
stroke. Impairment levels were mild to moderate (National 
Institute for Health Stroke Scale range = 0-8), with 55% of 
participants not achieving age- and gender-related distances 
on the 6-minute walk test. There were no significant differ-
ences in baseline measures between the exercise and con-
trol groups (Table 1). To test the primary and secondary 
hypotheses within- and between-group differences were 
investigated for all outcomes.
Primary Outcomes
The effects of structured exercise on glucose control. Baseline 
fasted glucose levels in both groups were normal (<7·8 
mmol/L; Table 2). At baseline, 6 individuals (3 exercise and 
3 control) had impaired glucose tolerance (IGT; >7·8 to 
<11·1 mmol/L), and 3 (1 exercise and 2 control) had newly 
diagnosed type 2 diabetes mellitus (T2DM; >11.1 mmol/L). 
Neither a within- or between-group difference was demon-
strated postintervention in 2-hour glucose or baseline insu-
lin sensitivity (HOMA)(Table 2). Of the 3 exercisers 
starting with IGT status, 2 changed to levels within normal 
limits, and the individual with T2DM changed to IGT sta-
tus. Of the 3 controls with IGT, 1 changed to levels within 
normal limits, and the 2 with T2DM changed to IGT 
status.
The effects of exercise on CBF. There was no change in global 
gray matter CBF postintervention (Table 2). Regional anal-
ysis of medial temporal lobe CBF in the areas seen to suffer 
structural change (Figure 2: clusters 1 and 2) revealed a 
paired group increase in flow in the exercise group (38± 8 
vs 42 ± 10 mL/min/100 g, P = .05) but not in controls (41 ± 
8 vs 40 ± 7 mL/min/100 g, P = .27). A between-group dif-
ference in regional CBF was not observed.
Secondary Outcomes
Cerebral tissue volume. Paired regional analysis revealed a 
significant bilateral atrophy of the medial temporal lobe in 
the control group that was not observed in the exercise 
group (Figure 2). A between-group difference was not 
observed in cerebral tissue volume.
Cerebral metabolism. Good quality MR spectroscopy data 
were available only in 16 exercisers and 15 controls 
because of the technical challenges of acquiring spectros-
copy in the dentate gyrus. Analysis of the spectra of the 
ratio of N-acetylaspartate to creatine demonstrated no 
change following the intervention (Table 2).
Cardiorespiratory fitness. Significant within-group changes 
were demonstrated with exercise in peak oxygen consump-
tion (increased by 17%) and work rate (Table 2; Figure 3, 
panel A). There were significant between-group differences 
in peak oxygen consumption and peak work rate in favor of 
the exercise group (Table 2).
Blood pressure. A significant within-group increase was 
demonstrated in diastolic BP in the control group (Table 2). 
There was a significant between-group difference in resting 
diastolic but not systolic BP in favor of exercise (Table 2; 
Figure 3, Panel B).
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Lipid profile. A significant within-group improvement in 
HDL-C was observed with exercise (Table 2). HDL-C lev-
els increased significantly in the exercise group compared 
with controls (Table 2; Figure 3, panel C). Total cholesterol 
and LDL-C levels were unchanged in both groups follow-
ing the intervention (Table 2).
Body composition. Body mass index and composition were 
unchanged in both groups following the intervention 
(Table 2).
The Effects of Exercise on Clinical Outcomes
Significant within-group improvements were observed in 
both groups in measures of walking and balance. Significant 
within-group improvements were only made in the exercise 
group in cognition and stroke recovery, mood, strength, and 
overall physical activity. Significant between-group differ-
ences were demonstrated in favor of the exercise interven-
tion in walking ability, balance, cognition, mood, and 
overall stroke recovery (Table 3).
Figure 1. Participant flow diagram.
Abbreviations: MRI, magnetic resonance imaging; MMSE, Mini Mental State Examination.
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Protocol Feasibility
The trial protocol was deemed feasible because all the crite-
ria defined for success were achieved. It was found that 
100% (20/20) of the participants in the exercise group com-
pleted the intervention undertaking >90% of the outcome 
assessments and exercise sessions. No serious adverse 
events or other adverse events were reported over the course 
of the trial, indicating that interventions were safe and that 
the exercise protocol was delivered at the right intensity. 
Participants randomized to the exercise intervention group 
completed an average of 53 hours out of a possible 57 hours 
of exercise.
Discussion
This pilot study demonstrated for the first time that community-
based exercise therapy is a feasible short-term method of 
modifying metabolic risk factors and maintaining cerebral 
tissue volume in the medial temporal lobe, alongside improv-
ing physical function, cognition, and some aspects of quality 
of life, independent of changes in glucose control.
In contrast to our original hypothesis and data pub-
lished previously by another group,21 exercise did not 
have a significant effect on glucose control at a group 
level. It should be noted, however, that only 23% were 
defined as having T2DM or IGT following an oral glucose 
Table 1. Baseline Demographics and Clinical Characteristics.a
Variables Exercise Group (n = 20) Control Group (n = 20) P Value
Demographics
 Gender M/F 18/2 16/4 .39
 Age (years) 68 ± 8 70 ± 11 .49
 Body mass index (kg/m²) 26 ± 4 26 ± 4 .96
 Smoker/non smoker 1/19 3/17 .30
 Mini Mental State Examination 28 ± 2 29 ± 1 .52
 Months since stroke (range) 21 ± 34 (6-144) 16 ± 12 (6-43) .41
Stroke characteristics, n (%)
 Cerebral hemisphere
  Right 10 (50%) 11 (55%) .76
  Left 9 (45%) 7 (35%) .53
  Bilateral 1 (5%) 2 (10%) .56
Hemorrhagic stroke 1 2 .56
Vascular location of lesion
 Cortical 5 (25%) 3 (15%) .44
 Subcortical
  Basal ganglia 4 (20%) 3 (15%) .67
  Cerebellar 2 (10%) 3 (15%) .64
  Brain stem 0 (0%) 1 (5%) .32
  Thalamus 0 (0%) 1 (5%) .32
  Internal capsule 0 (0%) 1 (5%) .32
  Subcortical other 7 (35%) 6 (30%) .74
  Unknown 2 (10%) 2 (10%) 1·0
Functional characteristics
 NIHSS score 3 ± 3 (0-8) 2 ± 2 (0-7) .58
 Walking speed, m/s 1·2 ± 0·4 1·2 ± 0·3 .96
 6-Minute walk distance (m) 428 ± 131 419 ± 127 .84
Medication, n (%)
 β-Blocker 3 (15%) 6 (30%) .27
 ACE inhibitor 7 (35%) 11 (55%) .21
 Diuretic 5 (25%) 3 (15%) .44
 Antiarrhythmic 7 (35%) 3 (15%) .15
 Calcium channel blocker 2 (10%) 4 (20%) .39
 Statin 18 (90%) 17 (85%) .64
Abbreviations: M, male; F, female; NIHSS, National Institutes of Health Stroke Scale; ACE, angiotensin-converting-enzyme.
aData are mean ± standard deviation or mean unless otherwise stated.
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tolerance test in the present group, compared with 50% in 
the previous study.21 It is possible that the apparent stabil-
ity in glucose control following exercise reflects the num-
ber of study participants who already had adequate 
glucose control, rather than a lack of effect of exercise 
therapy on glucose regulation. Indeed, of the 4 partici-
pants with impaired glucose control in the exercise group, 
3 made clinically significant changes in glucose control. 
Independent of glucose control, however, there are signifi-
cant benefits of structured exercise for people living with 
stroke, which will now be discussed.
Analysis of the brain imaging data revealed significant 
atrophy of the medial temporal lobe in the control group 
over the 19-week study. In comparison, medial temporal 
lobe tissue structure was maintained, and regional blood 
flow was increased following exercise. Memory loss and 
brain atrophy occur with age.27 Age-related losses in brain 
volume are, however, not uniform, and interestingly, the 
medial temporal lobe is one of the areas where significant 
age-related loss occurs.43 It is also an area that plays a vital 
role in cognition.44 The fact that volume was maintained in 
this area with exercise and regional blood flow increased as 
well as the changes in cognition observed may indicate that 
exercise is a possible means of ameliorating age-related 
atrophy poststroke and improving long-term cognition. 
The only other study to observe the effect of exercise on 
CBF after stroke reported the impact of treadmill training 
on CBF assessed by transcranial Doppler and noted 
improvements in vasomotor reactivity.45 Our findings 
extend this work by using a quantitative direct measure of 
CBF with regional analysis. Our results demonstrate prom-
ising exercise-related changes in blood flow and cerebral 
atrophy, and although differences noted were within-group 
rather than between-group differences, these novel promis-
ing findings warrant further exploration in larger, better-
powered studies.
Table 2. Metabolic Risk Factors, Cerebral Blood Flow and Spectroscopy Outcomes.a
Exercise Control
Group × Time  
(95% CI) Variable Baseline 19 Weeks Δ P Value Baseline 19 Weeks Δ P Value
Metabolic risk factors
 Peak oxygen 
consumption  
(mL/kg/min)
18 ± 5 21 ± 5  3 <.01b 18 ± 5 18 ± 5  0 .62 <0.01b (1.3 to 5.2)
 Peak work rate (W) 112 ± 36 121 ± 37  9 <.01b 105 ± 34 101 ± 35 −4 .13 <0.01b (0.1 to 0.3)
 Systolic blood pressure 
(mm Hg)
137 ± 27 143 ± 19  6 .33 135 ± 13 137 ± 11  2 .50 0.64 (−10 to 16)
 Diastolic blood pressure 
(mm Hg)
84 ± 10 81 ± 11 −3 .32 83 ± 11 88 ± 10  5 .04c 0.04c (–14 to 0·4)
 Total cholesterol 
(mmol/L)
4.5 ± 1.2 4.7 ± 1.2 0.2 .47 4.4 ± 0.8 4.2 ± 0.8 −0.2 .36 0.33 (−0.3 to 0·9)
 LDL-C (mmol/L) 2.5 ± 0.9 2.5 ± 0.9  0 .75 2.5 ± 0.7 2.4 ± 0.7 −0.1 .96 0.79 (−0.5 to 0.6)
 HDL-C (mmol/L) 1.3 ± 0.4 1.6 ± 0.6 0.3 <.01b 1.4 ± 0·4 1.4 ± 0.3  0 .76 0.01c (0.05 to 0.4)
 HOMA index 1.5 ± 0.8 1.5 ± 0.7  0 .99 1.6 ± 0.8 1.7 ± 0.7 0.1 1.0 0.97 (−0.5 to 0.49)
 Two-hour glucose 
(mmol/L)
7 ± 2.7 6.4 ± 1.7 −0.6 0.17 6.8 ± 2.6 6.5 ± 2.2 −0.3 0.53 0.63 (−1.7 to 1.1)
 Body mass index (kg/m²) 26 ± 4 26 ± 4  0 0.06 26 ± 3 26 ± 4  0 0.45 0.25 (−0.7 to 0.2)
 Fat mass (%) 29 ± 9 28 ± 8 −1 0.07 32 ± 7 32 ± 9  0 0.89 0.22 (−3.8 to 0.9)
Brain physiology
 Gray matter CBF 
(mL/100 g/min)
34 ± 5 36 ± 14  2 0.39 35 ± 7 33 ± 6 −2 0.32 0.21 (−2.4 to 10.4)
 Medial temporal lobe 
region CBF  
(mL/100 g/min)
37·6 ± 8 42.2 ± 9.6 4.6 0.05c 41 ± 7.7 39.5 ± 7.2 −1.5 0.27 0.13 (−1.4 to 10.3)
 Dentate gyrus 
spectroscopy  
(NAA/Cr)
0.95 ± 0.34 1.01 ± 0.23 0.06 0.67 0.93 ± 0.28 0.98 ± 0.23 0.05 0.55 0.64 (−0.23 to 0.38)
aData are mean ± standard deviation unless otherwise stated.
bP < .01.
cP < .05.
Abbreviations: Group × Time, between group difference; CI, confidence interval; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density 
lipoprotein cholesterol; HOMA, homeostasis model of insulin sensitivity; CBF, cerebral blood flow; NAA/Cr, N-acetlyaspartate/creatine.
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Exercise produced significant short-term improvements 
in cardiorespiratory fitness, lipid profile, and blood pres-
sure. Cardiorespiratory fitness increased by 17% (3 mL/kg/
min) following exercise. Although this improvement may 
appear small, increasing cardiorespiratory fitness by 3 
mL/kg/min could potentially enable individuals with stroke 
to sustain light activities of daily living (requiring approxi-
mately 10.5 mL/kg/min) and undertake more vigorous 
activities such as fast walking/jogging (requiring approxi-
mately 21 mL/kg/min).46
Exercise resulted in a 23% increase (0.3 mmol/L) in 
HDL-C. A 0.06 mmol/L increase has been linked to a 6% 
reduction in coronary heart disease,47 and because 75% of 
stroke survivors present with cardiac disease,48 this is a 
finding worthy of further long-term exploration. Previous 
stroke studies have demonstrated no change in lipid pro-
file49 or changes in cholesterol and LDL-C, but not HDL-C, 
with exercise.50 Our study is unique in demonstrating that 
exercise can improve HDL-C poststroke; this improvement 
may have been a result of the length of the intervention and 
warrants further investigation.
Exercise reduced diastolic blood pressure by 3 mm Hg, 
which again could have led to reduction in stroke recurrence 
because a reduction of diastolic blood pressure of 4 mm Hg 
has been shown to reduce the relative risk of recurrent stroke 
by 28%.51 Only a small number of previous studies have 
observed the effect of exercise on blood pressure poststroke, 
with variable findings.50,52 A recent systematic review of 
lifestyle interventions for secondary stroke prevention dem-
onstrated that lifestyle interventions could potentially reduce 
blood pressure when combined with medication and medical 
guidelines.53 The effect on blood pressure should be further 
explored in a larger study because blood pressure is the main 
driver of vascular risk following stroke.5
Exercise led to clinically significant improvements in both 
walking speed (0·3 ± 0·14 m/s) and endurance (85 ± 47 m), 
supporting recent findings.14 Overall cognition, as measured 
by the ACE-R, improved with exercise, and this finding was 
in line with previous interventional studies in healthy indi-
viduals.54 Quality of life also increased in terms of mood and 
recovery, with promising within-group improvements in 
physical function and strength. At present, the impact of 
exercise on quality of life poststroke has yet to be deter-
mined,55 but the few trials that have explored this area dem-
onstrate that exercise can potentially improve quality of life, 
particularly in terms of mood and physical functioning.56-58
Reviewing all the results, it was encouraging to find sig-
nificant between-group differences in so many outcomes, 
Figure 2. SPM glass brain view and coordinates of specific gray matter atrophy in the control group after the intervention. Within-
group comparison showed significant bilateral atrophy of the medial temporal lobe in the control group (P < .05), whereas the 
exercise group showed no significant changes. Data are thresholded at P < .001 (uncorrected), applying a minimum cluster size (k > 
10). Coordinates of the significant differences are as follows:
Region Number x y z Cluster T Voxels
1 Parahippocampal gyrus Right 28 −8 −18 5.90 85
2 Parahippocampal gyrus Left −18 −14 −18 4.91 56
3 Lingual gyrus Right 2 −72 −2 4.42 42
4 Inferior putamen Right 30 10 −8 4.23 26
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given the size and the pilot nature of the study. This high-
lights the potential positive impact of this type of exercise 
intervention poststroke.
No participant left the exercise intervention or experi-
enced any adverse events, and participants attended more 
than 90% of the sessions over the 19 weeks. One of the 
most commonly reported barriers to exercise poststroke is 
transport.59 Although transport was not provided to the 
intervention and not all participants had access to a car, the 
high attendance rates indicate that in this instance, travel 
was not a barrier to adherence. Adherence to an exercise 
intervention is a key determinant of its success, so these 
findings are very encouraging.
Our study has some limitations. The groups were not 
matched for contact time with the research team, meaning 
that quality of life measures may have improved as a result 
of socialization rather than exercise. Because the primary 
outcome of the trial was based on physiological measures 
and not quality of life, an attention-matched control group 
was not deemed a primary objective. The decision not to 
have an attention-matched control group was made to opti-
mize retention because a matched control group with a 
stretching protocol similar to our own experienced high 
drop-out rates (>40%).21 The high drop-out rates could have 
confounded results, so it was decided that adherence with 
the intervention was more important than an attention-
matched control program. Although the exercise interven-
tion resulted in multiple short-term effects, our sample was 
relatively small and larger multicenter studies are needed to 
establish if these changes can be maintained over time and 
influence stroke recurrence and comorbidities. The cohort 
was predominantly male. The fact that women have higher 
prestroke disability, are more likely to live alone or in care, 
and have worse poststroke function60 may have led to low 
female recruitment and have implications for translating 
research findings for women into clinical care. Finally, the 
participants were self-selected and only had mild-moderate 
deficit (median National Institutes of Health Stroke Scale 
Figure 3. Changes in peak oxygen consumption (panel A), diastolic blood pressure (panel B), and high-density lipoprotein cholesterol 
HDL-C; panel C) preintervention and postintervention for exercise and control groups.a
aBetween-group difference; **P < .01; †P < .05. Red, exercise group; blue, controls.
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score = 3; range = 0-8), which may limit extension of these 
findings to people with more severe deficit.
Conclusions/Implications
In conclusion, this randomized controlled pilot trial dem-
onstrates that structured, community-delivered exercise 
therapy after stroke results in short-term improvements in 
metabolism, physical function, cognition, and quality of life 
and promising changes in cerebral atrophy/blood flow, inde-
pendent of changes in glucose control. The study protocol 
was deemed feasible, and larger studies should now be con-
ducted exploring the long-term effects of structured exercise 
on stroke recurrence, cardiovascular health, and disability.
Exercise Intervention.
Component Description Duration/Repetitions/Intensity
Warm-up •• Slow marching Five minutes/Low intensity
•• Slow marching with arm swing
•• Knee circle
•• Ankle circles





Functional strengthening •• Heel-toe raises 15 minutes/Start with 2 sets of 5 increase to 
3 sets of 10; variable speed•• Chair push-ups
•• Sit-to-stand
•• Sit-to-stand and walking around chair
•• Wall push-ups
•• Squat with a gym ball
Table 3. Clinical Outcomes: Walking Ability, Balance, Cognition, and Quality of Life.a
Exercise Control
Group × Time (95% 
CI) Variable Baseline 19 Weeks Δ P Value Baseline 19 Weeks Δ P Value
Physical function
 6-Minute walk test (m) 428 ± 131 513 ± 131 85 <.01b 419 ± 127 441 ± 126 22 .02c <0.01b (42 to 86)
 Walking speed (m/s) 1·2 ± 0.4 1.5 ± 0.3 0.3 <.01b 1.2 ± 0.3 1.3 ± 0.3 0.1 .04c <0.01b (0.1 to 0.3)
 Berg Balance Scale 50 ± 4 55 ± 2 5 <.01b 50 ± 5.6 52 ± 5 2 .04c <0.01b (0.9 to 5)
Cognition
 ACE-R 86 ± 8 92 ± 5 6 <.01b 89 ± 6 91 ± 8 2 .19 0.04c (0.29 to 7.8)
Quality of life: Stroke Impact Scale
 Stroke recovery 66 ± 28 79 ± 22 13 <.01b 79 ± 22 82 ± 17 3 .1 0.05c (0.3 to 21)
 Mood 77 ± 24 87 ± 12 10 .02c 85 ± 19 84 ± 18 −1 .60 0.02c (2.2 to 20)
 Strength 74 ± 27 79 ± 23 5 .04c 78 ± 21 83 ± 18 5 .23 0.77 (−8 to 10)
 Memory 85 ± 19 85 ± 18 0 .81 87 ± 19 90 ± 13 3 .52 0.64 (−9.9 to 6)
 Communication 87 ± 21 88 ± 19 1 .70 96 ± 6 95 ± 6 −1 .76 0.62 (−6 to 9)
 Activities of daily living 82 ± 19 85 ± 25 3 .42 90 ± 17 90 ± 15 0 .75 0.39 (−3 to 8)
 Community mobility 86 ± 25 91 ± 19 5 .08 90 ± 16 91 ± 12 1 .40 0.26 (−3 to 10)
 Hand 66 ± 42 69 ± 42 3 .13 78 ± 31 85 ± 28 7 .07 0.42 (−11 to 4.9)
 Participation 72 ± 29 76 ± 28 4 .53 89 ± 18 89 ± 18 0 .17 0.31 (−7 to 21)
 Physical total 308 ± 92 324 ± 96 16 .03c 336 ± 78 348 ± 64 12 .10 0.67 (−15 to 24)
Abbreviations: Group × Time, between-group difference; CI, confidence interval; ACE-R, Addenbrooke’s Cognitive Examination–Revised;.
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Component Description Duration/Repetitions/Intensity
Balance •• Forward reach 15 Minutes
•• Heel-to-toe standing and walking
•• Walking and change direction
•• Standing on 1 leg
•• Hip flexion, abduction, and extension
Agility and fitness •• Forward, side, and box step onto a step 15 Minutes/Start with 5 minutes of exercise 
gradually increase to 15 minutes/Perceived 
exertion should be 4-5 out of 10 on Borg 
scale (fairly light to somewhat hard)/
To increase intensity add hand weights, 
increase the height of the step








Cool down •• Combination of warm-up and stretches Five minutes/Low intensity
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